 Kenneth MacLean
Concepts (426)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Homocystinuria | 13 | 2021 | 62 | 5.690 |
Why?
| | Cystathionine beta-Synthase | 18 | 2021 | 59 | 4.660 |
Why?
| | Taurine | 6 | 2020 | 41 | 2.720 |
Why?
| | Betaine | 9 | 2021 | 63 | 2.200 |
Why?
| | Liver | 14 | 2024 | 1631 | 2.040 |
Why?
| | Homocysteine | 10 | 2021 | 136 | 1.540 |
Why?
| | Betaine-Homocysteine S-Methyltransferase | 2 | 2019 | 11 | 1.040 |
Why?
| | Down Syndrome | 10 | 2023 | 338 | 0.980 |
Why?
| | Methionine | 4 | 2021 | 144 | 0.920 |
Why?
| | Disease Models, Animal | 20 | 2021 | 3542 | 0.780 |
Why?
| | Mice | 40 | 2024 | 14916 | 0.750 |
Why?
| | Cysteine | 4 | 2020 | 171 | 0.710 |
Why?
| | Fatty Liver | 6 | 2013 | 213 | 0.660 |
Why?
| | Sulfur | 2 | 2014 | 46 | 0.630 |
Why?
| | Choline | 2 | 2017 | 106 | 0.610 |
Why?
| | Sulfinic Acids | 1 | 2018 | 7 | 0.600 |
Why?
| | Sulfhydryl Compounds | 2 | 2018 | 177 | 0.600 |
Why?
| | Pyruvaldehyde | 1 | 2018 | 27 | 0.590 |
Why?
| | Aminobutyrates | 1 | 2018 | 32 | 0.590 |
Why?
| | Endoplasmic Reticulum | 5 | 2014 | 234 | 0.580 |
Why?
| | Phosphatidylethanolamine N-Methyltransferase | 1 | 2017 | 8 | 0.570 |
Why?
| | Animals | 45 | 2024 | 31761 | 0.570 |
Why?
| | Mice, Inbred C57BL | 19 | 2024 | 4710 | 0.540 |
Why?
| | Mice, Knockout | 10 | 2020 | 2582 | 0.520 |
Why?
| | Induced Pluripotent Stem Cells | 3 | 2023 | 182 | 0.510 |
Why?
| | Non-alcoholic Fatty Liver Disease | 4 | 2024 | 245 | 0.510 |
Why?
| | Phospholipids | 1 | 2017 | 197 | 0.510 |
Why?
| | Cystathionine | 2 | 2012 | 25 | 0.500 |
Why?
| | Methylenetetrahydrofolate Reductase (NADPH2) | 4 | 2021 | 34 | 0.490 |
Why?
| | Apolipoprotein A-I | 2 | 2012 | 25 | 0.480 |
Why?
| | Thrombosis | 2 | 2011 | 297 | 0.470 |
Why?
| | Hepatocytes | 3 | 2024 | 196 | 0.470 |
Why?
| | Neural Stem Cells | 4 | 2023 | 115 | 0.460 |
Why?
| | Apolipoproteins A | 1 | 2012 | 18 | 0.410 |
Why?
| | Aryldialkylphosphatase | 1 | 2012 | 18 | 0.400 |
Why?
| | Mice, Transgenic | 10 | 2021 | 1951 | 0.390 |
Why?
| | Fragile X Syndrome | 2 | 2009 | 64 | 0.390 |
Why?
| | Hydrogen Sulfide | 2 | 2020 | 40 | 0.350 |
Why?
| | Transcription Factors | 9 | 2013 | 1528 | 0.350 |
Why?
| | Chemokines | 1 | 2011 | 213 | 0.350 |
Why?
| | Trans-Activators | 3 | 2007 | 368 | 0.340 |
Why?
| | Biomarkers | 2 | 2019 | 3414 | 0.330 |
Why?
| | Lipids | 1 | 2012 | 582 | 0.310 |
Why?
| | Endoplasmic Reticulum Stress | 3 | 2014 | 91 | 0.310 |
Why?
| | Dietary Supplements | 4 | 2014 | 460 | 0.310 |
Why?
| | Oxidation-Reduction | 5 | 2020 | 927 | 0.310 |
Why?
| | Saccharomyces cerevisiae | 2 | 2002 | 477 | 0.290 |
Why?
| | Urination Disorders | 1 | 2007 | 11 | 0.290 |
Why?
| | Apoptosis | 3 | 2013 | 2369 | 0.290 |
Why?
| | Male | 30 | 2024 | 55554 | 0.290 |
Why?
| | Ectodermal Dysplasia | 1 | 2007 | 15 | 0.290 |
Why?
| | Cleft Lip | 1 | 2007 | 32 | 0.280 |
Why?
| | Cleft Palate | 1 | 2007 | 46 | 0.280 |
Why?
| | Fingers | 1 | 2007 | 83 | 0.270 |
Why?
| | Metabolome | 2 | 2021 | 283 | 0.270 |
Why?
| | DNA-Binding Proteins | 4 | 2007 | 1314 | 0.270 |
Why?
| | Myoblasts | 1 | 2007 | 76 | 0.270 |
Why?
| | Protein Precursors | 1 | 2007 | 119 | 0.270 |
Why?
| | Abnormalities, Multiple | 2 | 2007 | 177 | 0.270 |
Why?
| | Oxidative Stress | 6 | 2022 | 1084 | 0.270 |
Why?
| | Cystathionine gamma-Lyase | 3 | 2020 | 11 | 0.260 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2007 | 185 | 0.250 |
Why?
| | Amino Acids | 2 | 2020 | 448 | 0.250 |
Why?
| | Trisomy | 4 | 2017 | 68 | 0.240 |
Why?
| | Tumor Suppressor Proteins | 1 | 2007 | 282 | 0.240 |
Why?
| | Mutation | 5 | 2021 | 3349 | 0.230 |
Why?
| | Sp1 Transcription Factor | 1 | 2003 | 23 | 0.230 |
Why?
| | Nuclear Proteins | 2 | 2013 | 592 | 0.230 |
Why?
| | Humans | 34 | 2024 | 114709 | 0.220 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2021 | 271 | 0.220 |
Why?
| | Myocytes, Cardiac | 1 | 2007 | 448 | 0.210 |
Why?
| | S-Adenosylmethionine | 4 | 2006 | 54 | 0.210 |
Why?
| | Uterine Artery | 2 | 2020 | 67 | 0.210 |
Why?
| | Connective Tissue | 1 | 2002 | 36 | 0.200 |
Why?
| | Cells | 1 | 2002 | 22 | 0.200 |
Why?
| | Diet, High-Fat | 2 | 2024 | 225 | 0.200 |
Why?
| | Female | 21 | 2021 | 59483 | 0.190 |
Why?
| | Stress, Psychological | 1 | 2009 | 944 | 0.190 |
Why?
| | Mitochondria | 3 | 2023 | 751 | 0.190 |
Why?
| | Insulin Resistance | 2 | 2024 | 1072 | 0.190 |
Why?
| | Adenosylhomocysteinase | 1 | 2021 | 10 | 0.190 |
Why?
| | Glycine Hydroxymethyltransferase | 1 | 2021 | 15 | 0.190 |
Why?
| | tau Proteins | 2 | 2012 | 68 | 0.190 |
Why?
| | Liver Failure | 1 | 2021 | 75 | 0.180 |
Why?
| | Polyamines | 1 | 2021 | 35 | 0.180 |
Why?
| | Heme | 1 | 2000 | 52 | 0.180 |
Why?
| | Mutation, Missense | 1 | 2002 | 295 | 0.180 |
Why?
| | Oxidoreductases Acting on Sulfur Group Donors | 1 | 2020 | 11 | 0.180 |
Why?
| | Ethanol | 2 | 2016 | 548 | 0.180 |
Why?
| | Lipotropic Agents | 2 | 2012 | 5 | 0.180 |
Why?
| | Leigh Disease | 1 | 2020 | 17 | 0.180 |
Why?
| | Quinone Reductases | 1 | 2020 | 15 | 0.180 |
Why?
| | Myometrium | 1 | 2020 | 35 | 0.170 |
Why?
| | Association Learning | 2 | 2011 | 60 | 0.170 |
Why?
| | Lipogenesis | 3 | 2019 | 57 | 0.170 |
Why?
| | Cell Differentiation | 6 | 2023 | 1699 | 0.170 |
Why?
| | Umbilical Arteries | 1 | 2020 | 41 | 0.170 |
Why?
| | Folic Acid | 1 | 2021 | 161 | 0.170 |
Why?
| | Growth Differentiation Factor 10 | 1 | 2019 | 1 | 0.170 |
Why?
| | SNARE Proteins | 1 | 2019 | 37 | 0.170 |
Why?
| | Interleukin-1beta | 2 | 2011 | 370 | 0.160 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2018 | 141 | 0.160 |
Why?
| | Glutathione | 3 | 2020 | 300 | 0.160 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2020 | 235 | 0.160 |
Why?
| | Hyperhomocysteinemia | 2 | 2009 | 24 | 0.160 |
Why?
| | PPAR gamma | 1 | 2019 | 182 | 0.150 |
Why?
| | Brachial Artery | 1 | 2019 | 176 | 0.150 |
Why?
| | gamma-Glutamyltransferase | 1 | 2018 | 42 | 0.150 |
Why?
| | Inflammation | 4 | 2019 | 2481 | 0.150 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2011 | 1134 | 0.150 |
Why?
| | Respiratory Hypersensitivity | 1 | 2018 | 60 | 0.150 |
Why?
| | Autophagy | 1 | 2019 | 233 | 0.140 |
Why?
| | Proteostasis Deficiencies | 1 | 2017 | 6 | 0.140 |
Why?
| | Hep G2 Cells | 2 | 2019 | 61 | 0.140 |
Why?
| | Estradiol | 1 | 2020 | 455 | 0.140 |
Why?
| | Recombinant Proteins | 1 | 2000 | 1233 | 0.140 |
Why?
| | Cell Death | 2 | 2024 | 322 | 0.140 |
Why?
| | Chemical and Drug Induced Liver Injury, Chronic | 1 | 2016 | 9 | 0.130 |
Why?
| | Obesity | 3 | 2024 | 2513 | 0.130 |
Why?
| | Fatty Liver, Alcoholic | 1 | 2016 | 16 | 0.130 |
Why?
| | Child, Preschool | 5 | 2020 | 9077 | 0.130 |
Why?
| | Transcription Factor TFIIIB | 1 | 1995 | 1 | 0.130 |
Why?
| | Chromosomes, Human, Pair 14 | 1 | 1995 | 16 | 0.130 |
Why?
| | Diet | 3 | 2011 | 1080 | 0.130 |
Why?
| | Cells, Cultured | 6 | 2022 | 3890 | 0.130 |
Why?
| | PTEN Phosphohydrolase | 1 | 2016 | 140 | 0.120 |
Why?
| | Fetal Growth Retardation | 1 | 2020 | 467 | 0.120 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2018 | 452 | 0.120 |
Why?
| | Host Cell Factor C1 | 1 | 2014 | 13 | 0.120 |
Why?
| | Protein Processing, Post-Translational | 1 | 2017 | 399 | 0.120 |
Why?
| | Adult | 6 | 2020 | 30542 | 0.120 |
Why?
| | Cysteine Dioxygenase | 1 | 2014 | 3 | 0.120 |
Why?
| | Carboxy-Lyases | 1 | 2014 | 8 | 0.120 |
Why?
| | Triglycerides | 5 | 2018 | 470 | 0.120 |
Why?
| | Fibroblasts | 3 | 2012 | 838 | 0.120 |
Why?
| | Phenotype | 4 | 2021 | 2811 | 0.120 |
Why?
| | Cognition | 2 | 2012 | 983 | 0.110 |
Why?
| | Sulfurtransferases | 1 | 2013 | 9 | 0.110 |
Why?
| | Glutaredoxins | 1 | 2013 | 11 | 0.110 |
Why?
| | Escherichia coli | 3 | 2002 | 722 | 0.110 |
Why?
| | Heat-Shock Proteins | 1 | 2014 | 113 | 0.110 |
Why?
| | Cholesterol | 2 | 2013 | 368 | 0.110 |
Why?
| | Cell Line | 3 | 2019 | 2639 | 0.110 |
Why?
| | Liver Diseases, Alcoholic | 1 | 2014 | 83 | 0.110 |
Why?
| | Adenosine Triphosphatases | 1 | 2014 | 153 | 0.110 |
Why?
| | Hyperglycinemia, Nonketotic | 1 | 2013 | 42 | 0.110 |
Why?
| | Peroxiredoxins | 1 | 2013 | 23 | 0.110 |
Why?
| | Aldehydes | 1 | 2014 | 142 | 0.110 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2014 | 316 | 0.110 |
Why?
| | Molecular Sequence Data | 5 | 2003 | 2791 | 0.110 |
Why?
| | Young Adult | 3 | 2020 | 10461 | 0.110 |
Why?
| | Blotting, Western | 2 | 2014 | 1151 | 0.110 |
Why?
| | Avoidance Learning | 2 | 2012 | 63 | 0.100 |
Why?
| | Tunicamycin | 1 | 2012 | 11 | 0.100 |
Why?
| | Child | 4 | 2019 | 18348 | 0.100 |
Why?
| | Protein Denaturation | 1 | 2012 | 68 | 0.100 |
Why?
| | Carboxylic Ester Hydrolases | 1 | 2012 | 15 | 0.100 |
Why?
| | Adolescent | 3 | 2019 | 17806 | 0.100 |
Why?
| | Hypoxia | 1 | 2018 | 957 | 0.100 |
Why?
| | Brain | 3 | 2012 | 2369 | 0.100 |
Why?
| | Metabolomics | 1 | 2017 | 527 | 0.100 |
Why?
| | Zebrafish Proteins | 1 | 2014 | 246 | 0.100 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 928 | 0.100 |
Why?
| | Galantamine | 1 | 2011 | 3 | 0.100 |
Why?
| | Lyases | 1 | 2012 | 9 | 0.100 |
Why?
| | Fragile X Mental Retardation Protein | 2 | 2009 | 51 | 0.100 |
Why?
| | Promoter Regions, Genetic | 4 | 2005 | 1133 | 0.100 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2013 | 175 | 0.100 |
Why?
| | Palmitic Acid | 1 | 2011 | 36 | 0.100 |
Why?
| | Necrosis | 1 | 2012 | 210 | 0.100 |
Why?
| | Neuroblastoma | 1 | 2012 | 132 | 0.100 |
Why?
| | Cell Line, Tumor | 2 | 2011 | 2725 | 0.100 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2014 | 799 | 0.100 |
Why?
| | RNA, Messenger | 3 | 2014 | 2557 | 0.090 |
Why?
| | Chemokine CCL4 | 1 | 2011 | 21 | 0.090 |
Why?
| | Sucrose | 1 | 2011 | 91 | 0.090 |
Why?
| | Proteins | 2 | 2013 | 912 | 0.090 |
Why?
| | Methylation | 1 | 2011 | 208 | 0.090 |
Why?
| | Stem Cell Transplantation | 1 | 2012 | 149 | 0.090 |
Why?
| | Dietary Fats | 1 | 2013 | 287 | 0.090 |
Why?
| | Interleukin-1alpha | 1 | 2011 | 55 | 0.090 |
Why?
| | Interleukin-17 | 1 | 2011 | 104 | 0.090 |
Why?
| | Cell Adhesion Molecules, Neuronal | 1 | 2010 | 35 | 0.090 |
Why?
| | Carrier Proteins | 1 | 2014 | 696 | 0.090 |
Why?
| | Alcohol Drinking | 1 | 2016 | 654 | 0.090 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2011 | 123 | 0.090 |
Why?
| | HEK293 Cells | 1 | 2012 | 593 | 0.090 |
Why?
| | Serine Endopeptidases | 1 | 2010 | 102 | 0.090 |
Why?
| | Blood Coagulation | 1 | 2011 | 217 | 0.090 |
Why?
| | Hemostasis | 1 | 2010 | 67 | 0.090 |
Why?
| | Hippocampus | 2 | 2012 | 695 | 0.080 |
Why?
| | Cell Division | 2 | 2002 | 759 | 0.080 |
Why?
| | Extracellular Matrix Proteins | 1 | 2010 | 126 | 0.080 |
Why?
| | Atherosclerosis | 1 | 2013 | 342 | 0.080 |
Why?
| | Freezing Reaction, Cataleptic | 1 | 2009 | 22 | 0.080 |
Why?
| | Animals, Newborn | 3 | 2021 | 777 | 0.080 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 2 | 2024 | 54 | 0.080 |
Why?
| | Acetylcysteine | 1 | 2010 | 142 | 0.080 |
Why?
| | Hypertriglyceridemia | 1 | 2009 | 34 | 0.080 |
Why?
| | Swimming | 1 | 2009 | 44 | 0.080 |
Why?
| | Kinetics | 3 | 2020 | 1550 | 0.080 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2007 | 345 | 0.080 |
Why?
| | Restraint, Physical | 1 | 2009 | 67 | 0.080 |
Why?
| | Electroshock | 1 | 2009 | 134 | 0.080 |
Why?
| | Base Sequence | 4 | 2003 | 2118 | 0.080 |
Why?
| | Genetic Variation | 1 | 2013 | 876 | 0.080 |
Why?
| | Infant | 5 | 2019 | 7932 | 0.080 |
Why?
| | Liver Cirrhosis | 1 | 2010 | 228 | 0.080 |
Why?
| | Embryonic Development | 2 | 2006 | 117 | 0.080 |
Why?
| | Corticosterone | 1 | 2009 | 211 | 0.080 |
Why?
| | Cognition Disorders | 1 | 2012 | 476 | 0.080 |
Why?
| | Gene Expression Regulation | 4 | 2019 | 2321 | 0.080 |
Why?
| | Fibrosis | 1 | 2010 | 453 | 0.080 |
Why?
| | Blood Coagulation Disorders | 1 | 2010 | 192 | 0.070 |
Why?
| | Exploratory Behavior | 1 | 2008 | 82 | 0.070 |
Why?
| | Pregnancy | 5 | 2020 | 5524 | 0.070 |
Why?
| | Memory | 1 | 2009 | 209 | 0.070 |
Why?
| | Aging | 3 | 2012 | 1620 | 0.070 |
Why?
| | Rats | 3 | 2011 | 4943 | 0.070 |
Why?
| | Interleukin-6 | 1 | 2011 | 675 | 0.070 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2007 | 32 | 0.070 |
Why?
| | Attention | 1 | 2010 | 392 | 0.070 |
Why?
| | Lamin Type A | 1 | 2007 | 40 | 0.070 |
Why?
| | Taste | 1 | 2009 | 209 | 0.070 |
Why?
| | Glutamine | 1 | 2007 | 91 | 0.070 |
Why?
| | Nerve Tissue Proteins | 1 | 2010 | 529 | 0.070 |
Why?
| | Point Mutation | 1 | 2007 | 216 | 0.070 |
Why?
| | Syndrome | 1 | 2007 | 334 | 0.070 |
Why?
| | Pedigree | 1 | 2007 | 464 | 0.070 |
Why?
| | Chromosomes, Human, Pair 8 | 1 | 2006 | 33 | 0.070 |
Why?
| | Arginine | 1 | 2007 | 236 | 0.070 |
Why?
| | Structure-Activity Relationship | 1 | 2007 | 503 | 0.060 |
Why?
| | Glucose-6-Phosphatase | 1 | 2005 | 31 | 0.060 |
Why?
| | Placental Circulation | 1 | 2006 | 56 | 0.060 |
Why?
| | Emotions | 1 | 2010 | 472 | 0.060 |
Why?
| | Social Behavior | 1 | 2008 | 268 | 0.060 |
Why?
| | Models, Biological | 1 | 2012 | 1630 | 0.060 |
Why?
| | Amino Acid Sequence | 3 | 2014 | 1988 | 0.060 |
Why?
| | Neovascularization, Physiologic | 1 | 2006 | 173 | 0.060 |
Why?
| | Trophoblasts | 1 | 2006 | 163 | 0.060 |
Why?
| | Sp3 Transcription Factor | 1 | 2003 | 6 | 0.060 |
Why?
| | Serum Albumin | 1 | 2004 | 134 | 0.060 |
Why?
| | Alanine Transaminase | 2 | 2016 | 141 | 0.060 |
Why?
| | Anti-Bacterial Agents | 1 | 2012 | 1477 | 0.050 |
Why?
| | Organ Specificity | 1 | 2003 | 268 | 0.050 |
Why?
| | Repressor Proteins | 1 | 2006 | 367 | 0.050 |
Why?
| | United States | 1 | 2019 | 12175 | 0.050 |
Why?
| | Blood Physiological Phenomena | 1 | 2002 | 14 | 0.050 |
Why?
| | Carbon-Carbon Ligases | 1 | 2002 | 2 | 0.050 |
Why?
| | Reperfusion Injury | 1 | 2004 | 254 | 0.050 |
Why?
| | Propionates | 1 | 2002 | 34 | 0.050 |
Why?
| | DNA, Complementary | 2 | 2000 | 257 | 0.050 |
Why?
| | Enzyme Stability | 1 | 2002 | 62 | 0.050 |
Why?
| | Cricetulus | 1 | 2002 | 97 | 0.050 |
Why?
| | Cloning, Molecular | 2 | 2000 | 524 | 0.050 |
Why?
| | Genotype | 1 | 2007 | 1773 | 0.050 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2000 | 353 | 0.050 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 2002 | 83 | 0.050 |
Why?
| | Cricetinae | 1 | 2002 | 254 | 0.050 |
Why?
| | Anxiety | 1 | 2008 | 840 | 0.050 |
Why?
| | Green Fluorescent Proteins | 2 | 2014 | 373 | 0.050 |
Why?
| | Isoenzymes | 1 | 2002 | 285 | 0.050 |
Why?
| | DNA Mutational Analysis | 1 | 2002 | 372 | 0.050 |
Why?
| | Pyridoxal Phosphate | 1 | 2000 | 20 | 0.050 |
Why?
| | Glucose | 1 | 2005 | 897 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2002 | 854 | 0.040 |
Why?
| | Chromosome Mapping | 2 | 2006 | 489 | 0.040 |
Why?
| | In Situ Hybridization, Fluorescence | 2 | 2006 | 313 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2023 | 536 | 0.040 |
Why?
| | Carbon | 1 | 2021 | 157 | 0.040 |
Why?
| | Acidosis, Lactic | 1 | 2020 | 27 | 0.040 |
Why?
| | Ovariectomy | 1 | 2020 | 116 | 0.040 |
Why?
| | Electron Transport Complex IV | 1 | 2020 | 53 | 0.040 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 319 | 0.040 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 1 | 2019 | 26 | 0.040 |
Why?
| | R-SNARE Proteins | 1 | 2019 | 18 | 0.040 |
Why?
| | Down-Regulation | 1 | 2002 | 596 | 0.040 |
Why?
| | Pregnancy Trimester, Third | 1 | 2020 | 78 | 0.040 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2020 | 125 | 0.040 |
Why?
| | Homozygote | 1 | 2020 | 187 | 0.040 |
Why?
| | Mice, Mutant Strains | 2 | 2011 | 271 | 0.040 |
Why?
| | Catalysis | 1 | 2000 | 292 | 0.040 |
Why?
| | Ultrasonography, Doppler | 1 | 2020 | 105 | 0.040 |
Why?
| | Infant, Small for Gestational Age | 1 | 2020 | 76 | 0.040 |
Why?
| | Infant, Newborn | 2 | 2020 | 5034 | 0.040 |
Why?
| | Lysosomes | 1 | 2019 | 123 | 0.040 |
Why?
| | Behavior, Animal | 2 | 2012 | 460 | 0.040 |
Why?
| | Progesterone | 1 | 2020 | 232 | 0.040 |
Why?
| | Brain Diseases | 1 | 2020 | 124 | 0.040 |
Why?
| | Macaca | 1 | 2018 | 50 | 0.040 |
Why?
| | Citric Acid Cycle | 1 | 2018 | 43 | 0.040 |
Why?
| | Polymerase Chain Reaction | 2 | 2005 | 994 | 0.040 |
Why?
| | Ligands | 1 | 2000 | 564 | 0.040 |
Why?
| | Microtubule-Associated Proteins | 1 | 2019 | 174 | 0.040 |
Why?
| | Ultrasonography, Prenatal | 1 | 2020 | 236 | 0.040 |
Why?
| | Gluconeogenesis | 1 | 2018 | 62 | 0.040 |
Why?
| | Diet, Western | 1 | 2018 | 66 | 0.040 |
Why?
| | Protein Transport | 1 | 2019 | 396 | 0.040 |
Why?
| | Estrogens | 1 | 2020 | 312 | 0.040 |
Why?
| | Ultraviolet Rays | 1 | 2000 | 366 | 0.040 |
Why?
| | Pregnancy Outcome | 1 | 2020 | 337 | 0.040 |
Why?
| | Mass Spectrometry | 1 | 2000 | 633 | 0.040 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2017 | 31 | 0.040 |
Why?
| | Gestational Age | 1 | 2020 | 759 | 0.040 |
Why?
| | Homeostasis | 1 | 2020 | 575 | 0.040 |
Why?
| | Alternative Splicing | 1 | 1998 | 188 | 0.030 |
Why?
| | RNA-Binding Proteins | 1 | 2019 | 344 | 0.030 |
Why?
| | Fatty Acids | 1 | 2019 | 382 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2024 | 1745 | 0.030 |
Why?
| | Family | 1 | 2020 | 590 | 0.030 |
Why?
| | Protein Carbonylation | 1 | 2016 | 51 | 0.030 |
Why?
| | Hybrid Cells | 1 | 1995 | 49 | 0.030 |
Why?
| | Quantitative Trait Loci | 1 | 2018 | 307 | 0.030 |
Why?
| | Immunohistochemistry | 2 | 2012 | 1635 | 0.030 |
Why?
| | TATA-Binding Protein Associated Factors | 1 | 1995 | 15 | 0.030 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 84 | 0.030 |
Why?
| | Pilot Projects | 1 | 2020 | 1370 | 0.030 |
Why?
| | Genes, Immediate-Early | 1 | 1995 | 15 | 0.030 |
Why?
| | Middle Aged | 2 | 2007 | 26747 | 0.030 |
Why?
| | Immediate-Early Proteins | 1 | 1995 | 52 | 0.030 |
Why?
| | Branchial Region | 1 | 2014 | 33 | 0.030 |
Why?
| | Unfolded Protein Response | 1 | 2014 | 43 | 0.030 |
Why?
| | Craniofacial Abnormalities | 1 | 2014 | 59 | 0.030 |
Why?
| | Oxidoreductases | 1 | 2014 | 92 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2016 | 399 | 0.030 |
Why?
| | Vitamin B 12 | 1 | 2014 | 115 | 0.030 |
Why?
| | Body Patterning | 1 | 2014 | 126 | 0.030 |
Why?
| | DNA Methylation | 1 | 2018 | 496 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2014 | 299 | 0.030 |
Why?
| | Neural Crest | 1 | 2014 | 117 | 0.030 |
Why?
| | Atrophy | 1 | 2013 | 151 | 0.030 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2013 | 33 | 0.030 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2013 | 24 | 0.030 |
Why?
| | Fatal Outcome | 1 | 2013 | 284 | 0.030 |
Why?
| | Protein Folding | 1 | 2014 | 239 | 0.030 |
Why?
| | Gene Expression | 1 | 2018 | 1420 | 0.030 |
Why?
| | 3T3-L1 Cells | 1 | 2012 | 31 | 0.030 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 1995 | 333 | 0.030 |
Why?
| | Drinking Behavior | 1 | 2012 | 10 | 0.030 |
Why?
| | Thermogenesis | 1 | 2012 | 37 | 0.030 |
Why?
| | Chondrocytes | 1 | 2014 | 199 | 0.030 |
Why?
| | Dentate Gyrus | 1 | 2012 | 30 | 0.030 |
Why?
| | Cell Size | 1 | 2012 | 80 | 0.030 |
Why?
| | Maze Learning | 1 | 2012 | 86 | 0.030 |
Why?
| | Organ Size | 1 | 2013 | 435 | 0.020 |
Why?
| | Activating Transcription Factor 4 | 1 | 2012 | 18 | 0.020 |
Why?
| | Neuroimmunomodulation | 1 | 2012 | 70 | 0.020 |
Why?
| | Mitochondrial Proteins | 1 | 2013 | 219 | 0.020 |
Why?
| | Signal Transduction | 2 | 2016 | 4521 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2014 | 797 | 0.020 |
Why?
| | Nootropic Agents | 1 | 2011 | 27 | 0.020 |
Why?
| | Cell Count | 1 | 2012 | 305 | 0.020 |
Why?
| | Adiponectin | 1 | 2013 | 213 | 0.020 |
Why?
| | Mice, Inbred C3H | 1 | 2011 | 241 | 0.020 |
Why?
| | Embryo, Mammalian | 1 | 2012 | 214 | 0.020 |
Why?
| | Zebrafish | 1 | 2014 | 411 | 0.020 |
Why?
| | Odorants | 1 | 2011 | 128 | 0.020 |
Why?
| | Cell Movement | 1 | 2014 | 867 | 0.020 |
Why?
| | Stem Cells | 1 | 2014 | 546 | 0.020 |
Why?
| | Cohort Studies | 1 | 2020 | 4899 | 0.020 |
Why?
| | Time Factors | 1 | 2000 | 6122 | 0.020 |
Why?
| | Computer Simulation | 1 | 2014 | 878 | 0.020 |
Why?
| | Binding Sites | 2 | 2006 | 1176 | 0.020 |
Why?
| | Sinus of Valsalva | 1 | 2009 | 11 | 0.020 |
Why?
| | Random Allocation | 1 | 2010 | 335 | 0.020 |
Why?
| | Models, Molecular | 1 | 2014 | 1378 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1226 | 0.020 |
Why?
| | Lactation | 1 | 2010 | 151 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2020 | 3031 | 0.020 |
Why?
| | Apolipoproteins E | 1 | 2009 | 80 | 0.020 |
Why?
| | Visual Perception | 1 | 2010 | 138 | 0.020 |
Why?
| | Cell Survival | 1 | 2012 | 1021 | 0.020 |
Why?
| | Protein Binding | 1 | 2014 | 1896 | 0.020 |
Why?
| | Immunoblotting | 1 | 2009 | 283 | 0.020 |
Why?
| | Cholesterol, HDL | 1 | 2009 | 184 | 0.020 |
Why?
| | Choline Deficiency | 1 | 2007 | 11 | 0.020 |
Why?
| | Time | 1 | 2007 | 70 | 0.020 |
Why?
| | Energy Metabolism | 1 | 2012 | 729 | 0.020 |
Why?
| | Acute-Phase Reaction | 1 | 2007 | 39 | 0.020 |
Why?
| | Cytochrome P-450 CYP2E1 | 1 | 2007 | 27 | 0.020 |
Why?
| | eIF-2 Kinase | 1 | 2007 | 24 | 0.020 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2007 | 23 | 0.020 |
Why?
| | Transcription Factor CHOP | 1 | 2007 | 28 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2008 | 386 | 0.020 |
Why?
| | Lipase | 1 | 2007 | 57 | 0.020 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2007 | 144 | 0.020 |
Why?
| | Sequence Analysis, Protein | 1 | 2006 | 28 | 0.020 |
Why?
| | Animals, Genetically Modified | 1 | 2007 | 215 | 0.020 |
Why?
| | Tyrosine | 1 | 2007 | 215 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2009 | 1151 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2009 | 446 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2013 | 2537 | 0.020 |
Why?
| | Solvents | 1 | 2006 | 105 | 0.020 |
Why?
| | Placentation | 1 | 2006 | 40 | 0.020 |
Why?
| | Blotting, Southern | 1 | 2006 | 68 | 0.020 |
Why?
| | Snail Family Transcription Factors | 1 | 2006 | 19 | 0.020 |
Why?
| | Karyotyping | 1 | 2006 | 103 | 0.020 |
Why?
| | Executive Function | 1 | 2010 | 376 | 0.020 |
Why?
| | Gene Duplication | 1 | 2006 | 63 | 0.020 |
Why?
| | Nucleic Acid Hybridization | 1 | 2006 | 187 | 0.020 |
Why?
| | Alzheimer Disease | 1 | 2010 | 436 | 0.020 |
Why?
| | Kidney | 1 | 2012 | 1184 | 0.020 |
Why?
| | Tetralogy of Fallot | 1 | 2006 | 81 | 0.020 |
Why?
| | Aorta | 1 | 2007 | 386 | 0.010 |
Why?
| | Rats, Wistar | 1 | 2005 | 368 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2006 | 787 | 0.010 |
Why?
| | Mothers | 1 | 2010 | 651 | 0.010 |
Why?
| | DNA Primers | 1 | 2005 | 514 | 0.010 |
Why?
| | NF-kappa B | 1 | 2007 | 636 | 0.010 |
Why?
| | Body Weight | 1 | 2007 | 869 | 0.010 |
Why?
| | Biotinylation | 1 | 2002 | 27 | 0.010 |
Why?
| | Holoenzymes | 1 | 2002 | 21 | 0.010 |
Why?
| | Amino Acid Metabolism, Inborn Errors | 1 | 2002 | 19 | 0.010 |
Why?
| | Dimerization | 1 | 2002 | 176 | 0.010 |
Why?
| | Phosphorylation | 1 | 2005 | 1571 | 0.010 |
Why?
| | Placenta | 1 | 2006 | 626 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2006 | 1316 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2004 | 2209 | 0.010 |
Why?
| | Alu Elements | 1 | 1998 | 26 | 0.010 |
Why?
| | Minisatellite Repeats | 1 | 1998 | 38 | 0.010 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 1998 | 152 | 0.010 |
Why?
| | Exons | 1 | 1998 | 303 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2010 | 9089 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 1998 | 728 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 1998 | 612 | 0.010 |
Why?
| | Tristetraprolin | 1 | 1995 | 5 | 0.010 |
Why?
|
|
MacLean's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|